Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 2Active not recruiting 2Withdrawn 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Endometrial Neoplasms 6Cachexia 6Breast Neoplasms 4Anorexia 4Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Optic Nerve Glioma 1Oligodendroglioma 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Medulloblastoma 1Lymphoma 1Lung Neoplasms 1Liver Neoplasms 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Hairy Cell 1Leukemia 1Hot Flashes 1Head and Neck Neoplasms 1Fatigue 1Familial ependymoma 1Esthesioneuroblastoma, Olfactory 1

Interventions

exemestane 1Tamoxifen 1Pharmacogenomic Variants 1Metformin 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Immunohistochemistry 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Endometrial Hyperplasia × Megestrol Acetate × Clear all
NCT00483327 2018-04-04

Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate

NYU Langone Health

Phase 2 Completed
31 enrolled 9 charts
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡